Angion Biomedica Return On Equity vs. Total Debt
| ANGNDelisted Stock | USD 10.00 8.94 843.40% |
For Angion Biomedica profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Angion Biomedica to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Angion Biomedica Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Angion Biomedica's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Angion Biomedica Corp over time as well as its relative position and ranking within its peers.
Angion |
Angion Biomedica Corp Total Debt vs. Return On Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Angion Biomedica's current stock value. Our valuation model uses many indicators to compare Angion Biomedica value to that of its competitors to determine the firm's financial worth. Angion Biomedica Corp is number one stock in return on equity category among its peers. It also is the top company in total debt category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Angion Biomedica's earnings, one of the primary drivers of an investment's value.Angion Total Debt vs. Return On Equity
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Angion Biomedica |
| = | -0.54 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Angion Biomedica |
| = | 4.2 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Angion Total Debt vs Competition
Angion Biomedica Corp is the top company in total debt category among its peers. Total debt of Biotechnology industry is presently estimated at about 207.35 Million. Angion Biomedica holds roughly 4.2 Million in total debt claiming about 2.03% of stocks in Biotechnology industry.
Angion Biomedica Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Angion Biomedica, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Angion Biomedica will eventually generate negative long term returns. The profitability progress is the general direction of Angion Biomedica's change in net profit over the period of time. It can combine multiple indicators of Angion Biomedica, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company was incorporated in 1998 and is based in Uniondale, New York. Angion Biomedica operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 37 people.
Angion Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Angion Biomedica. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Angion Biomedica position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Angion Biomedica's important profitability drivers and their relationship over time.
Use Angion Biomedica in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Angion Biomedica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Angion Biomedica will appreciate offsetting losses from the drop in the long position's value.Angion Biomedica Pair Trading
Angion Biomedica Corp Pair Trading Analysis
The ability to find closely correlated positions to Angion Biomedica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Angion Biomedica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Angion Biomedica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Angion Biomedica Corp to buy it.
The correlation of Angion Biomedica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Angion Biomedica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Angion Biomedica Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Angion Biomedica can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Angion Biomedica position
In addition to having Angion Biomedica in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run USD Crypto Assets Thematic Idea Now
USD Crypto Assets
An experimental p2p digital currency that is accepted by many vendors in US Dollar. The USD Crypto Assets theme has 0 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize USD Crypto Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Angion Stock
If you are still planning to invest in Angion Biomedica Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Angion Biomedica's history and understand the potential risks before investing.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |